128 related articles for article (PubMed ID: 1963339)
1. Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors.
Iyengar S; Dilworth VM; Mick SJ; Contreras PC; Monahan JB; Rao TS; Wood PL
Brain Res; 1990 Aug; 524(2):322-6. PubMed ID: 1963339
[TBL] [Abstract][Full Text] [Related]
2. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
Gronier B; Debonnel G
Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
[TBL] [Abstract][Full Text] [Related]
3. (+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo.
Iyengar S; Wood PL; Mick SJ; Dilworth VM; Gray NM; Farah JM; Rao TS; Contreras PC
Neuropharmacology; 1991 Aug; 30(8):915-22. PubMed ID: 1723511
[TBL] [Abstract][Full Text] [Related]
4. Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo.
Iyengar S; Mick S; Dilworth V; Michel J; Rao TS; Farah JM; Wood PL
Neuropharmacology; 1990 Mar; 29(3):299-303. PubMed ID: 2158003
[TBL] [Abstract][Full Text] [Related]
5. MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cells.
Karasawa J; Yamamoto H; Yamamoto T; Sagi N; Horikomi K; Sora I
Life Sci; 2002 Feb; 70(14):1631-42. PubMed ID: 11991251
[TBL] [Abstract][Full Text] [Related]
6. Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands.
Gonzalez-Alvear GM; Werling LL
J Pharmacol Exp Ther; 1994 Oct; 271(1):212-9. PubMed ID: 7965717
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum.
Matsuno K; Matsunaga KH; Mita S
Neurochem Res; 1995 Feb; 20(2):233-8. PubMed ID: 7783846
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo.
Rao TS; Cler JA; Mick SJ; Dilworth VM; Contreras PC; Iyengar S; Wood PL
Neuropharmacology; 1990 Dec; 29(12):1191-7. PubMed ID: 1963476
[TBL] [Abstract][Full Text] [Related]
9. (+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue.
Booth RG; Baldessarini RJ
Brain Res; 1991 Aug; 557(1-2):349-52. PubMed ID: 1684130
[TBL] [Abstract][Full Text] [Related]
10. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
Hayashi T; Kagaya A; Takebayashi M; Shimizu M; Uchitomi Y; Motohashi N; Yamawaki S
J Pharmacol Exp Ther; 1995 Oct; 275(1):207-14. PubMed ID: 7562551
[TBL] [Abstract][Full Text] [Related]
11. Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates.
Boyce S; Rupniak NM; Steventon MJ; Cook G; Iversen SD
Behav Brain Res; 1991 Feb; 42(2):115-21. PubMed ID: 1647781
[TBL] [Abstract][Full Text] [Related]
12. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic.
Ceci A; Smith M; French ED
Eur J Pharmacol; 1988 Sep; 154(1):53-7. PubMed ID: 2903063
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment of rats with the specific sigma ligand D-pentazocine fails to modulate dopamine D2 and sigma binding in brain.
Weissman AD; De Souza EB
Eur J Pharmacol; 1991 Mar; 195(1):163-5. PubMed ID: 1648492
[TBL] [Abstract][Full Text] [Related]
14. Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat.
Sagratella S; Scotti de Carolis A; Pèzzola A; Popoli P
Psychopharmacology (Berl); 1991; 105(4):485-91. PubMed ID: 1685250
[TBL] [Abstract][Full Text] [Related]
15. Role of (+)-SKF-10,047-sensitive sub-population of sigma 1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems.
Kamei H; Noda Y; Kameyama T; Nabeshima T
Eur J Pharmacol; 1997 Jan; 319(2-3):165-72. PubMed ID: 9042587
[TBL] [Abstract][Full Text] [Related]
16. sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures.
Shimazu S; Katsuki H; Takenaka C; Tomita M; Kume T; Kaneko S; Akaike A
Eur J Pharmacol; 2000 Jan; 388(2):139-46. PubMed ID: 10666505
[TBL] [Abstract][Full Text] [Related]
17. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
Singh L; Wong EH; Kesingland AC; Tricklebank MD
Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
19. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
Pierce RC; Rebec GV
Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
[TBL] [Abstract][Full Text] [Related]
20. Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands.
Rao TS; Mick SJ; Cler JA; Emmett MR; Dilworth VM; Contreras PC; Gray NM; Wood PL; Iyengar S
Brain Res; 1991 Oct; 561(1):43-50. PubMed ID: 1686745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
